Q Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Q Therapeutics, Inc. reported Increase (Decrease) in Accounts Payable of $16.23 thousand for the 126-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2012-11-13
- Q Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2012-09-30 was -$153.53K.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2012-06-30 was $105.16K, a 53.51% increase year-over-year.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2012-03-31 was -$24.74K.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2011-12-31 was -$238.13K.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2011 was -$210.39K.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2011 was $63.27K.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2010 was -$39.70K.
- Q Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2010 was $225.00.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 67 month | Increase (Decrease) in Accounts Payable 70 month | Increase (Decrease) in Accounts Payable 117 month | Increase (Decrease) in Accounts Payable 120 month | Increase (Decrease) in Accounts Payable 123 month | Increase (Decrease) in Accounts Payable 126 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | -$153.53K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | -$48.37K derived: sum of 2 quarters · filed 2012-11-13 | -$73.11K 10-Q · filed 2012-11-13 | -$311.24K derived: sum of 4 quarters · filed 2012-11-13 | $16.23K 10-Q · filed 2012-11-13 | |||||
| 2012-06-30 | $105.16K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | $80.42K 10-Q/A · filed 2012-09-10 | -$157.71K derived: sum of 3 quarters · filed 2012-09-10 | -$194.24K derived: sum of 4 quarters · filed 2012-11-13 | $157.60K 10-Q/A · filed 2012-09-10 | |||||
| 2012-03-31 | -$24.74K 10-Q · filed 2012-05-16 | -$262.87K derived: sum of 2 quarters · filed 2012-05-16 | -$299.40K derived: sum of 3 quarters · filed 2012-11-13 | $52.44K 10-Q · filed 2012-05-16 | ||||||
| 2011-12-31 | -$238.13K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | -$274.66K derived: sum of 2 quarters · filed 2012-11-13 | -$210.39K 10-K · filed 2012-03-23 | $77.18K 10-K · filed 2012-03-23 | ||||||
| 2011-09-30 | -$36.53K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $27.74K 10-Q · filed 2012-11-13 | ||||||||
| 2011-08-31 | -$7.20K 10-Q · filed 2011-12-02 | $60.80K 10-Q · filed 2011-12-02 | ||||||||
| 2011-06-30 | $68.50K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | $64.27K 10-Q/A · filed 2012-09-10 | ||||||||
| 2011-05-31 | $63.27K 10-K/A · filed 2011-10-24 | $68.00K 10-K/A · filed 2011-10-24 | ||||||||
| 2011-03-31 | -$4.24K 10-Q · filed 2012-05-16 | |||||||||
| 2010-12-31 | -$39.70K 10-K · filed 2012-03-23 | |||||||||
| 2010-08-31 | $275.00 10-Q · filed 2011-12-02 | |||||||||
| 2010-05-31 | $225.00 10-K/A · filed 2011-10-24 |